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New  approach  of  the  detection  of  anthracycline  preparations  intercalating  native  DNA  has  been  pro-
posed  and  realized  in the assembly  of  electrochemical  sensor.  Glassy  carbon  was  covered  with polyaniline
obtained  by electropolymerization  in  the presence  of  native  DNA  and  oxalic acid  as  doping  agents.  As
was  shown  by  impedimetric  and  voltammetric  measurements,  the surface  coating  obtained  showed
extended  pH range  of  electrochemical  activity  and  retained  ability  to  interact  with  speciﬁc  intercalators.
The  incubation  of  the sensor  with  anthracycline  preparations  resulted  in  regular  decrease  of  electron
transfer  resistance  and  suppression  of redox  probe  current  (ferricyanide  anion).  In  optimal  conditions,
the  detection  limits  of 0.01 nM  doxorubicin,  0.1 nM daunorubicin  and  0.2 nM  idarubicin  were  achieved.
The  replacement  of oxalic  acid  with  sulfuric  acid  as  polymerization  media  as  well as  thermal  denatur-
ation  of DNA  resulted  in  disappearance  of  the  response.  The  selectivity  of  DNA  interaction  detection  was
higher in  weakly  acidic  media  for  impedimetric  measurements  and  in  HEPES,  pH  7.0,  for  voltammetric
detection.  Albumin,  blood  plasma  electrolytes  and  sulfanylamides  do  not  interfere  with  anthracycline
measurements.  The  electrochemical  sensor  developed  was  tested  in  the determination  of  doxorubicin  in
commercial  preparation  with  91–93%  recovery.
© 2015  Elsevier  B.V.  All  rights  reserved.
1. Introduction
Small molecules able to interact with DNA have found increasing
attention in the past decade due to enormous growth of their appli-
cations that mainly include visualization of DNA molecules in vitro
and inside the cells and antitumor chemotherapy [1]. Many mod-
ern antitumor drugs intercalate or modify DNA of cancer cells to
prevent their transcription and cancer cell division. Similar effect
is exerted on viruses. Intercalation assumes insertion of a planar
drug molecule between DNA base pairs followed by distortion of
the DNA helix, increasing its own volume and lengthening the DNA
molecule [2]. Some intercalators like doxorubicin can also promote
DNA damage by activation of the formation of reactive oxygen
species, stabilization of DNA cleavage complexes and inhibition
of reparation systems [3,4]. In spite of high efﬁciency, most anti-
cancer drugs are very toxic so that the gap between therapeutic and
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potentially dangerous dose is rather narrow and highly depends on
individual speciﬁcity of drug metabolism. For this reason as well
as for screening new less toxic pharmaceuticals, new methods are
demanded for fast and reliable detection of DNA targeting species.
The detection of DNA–drug intercalation is mainly based on
the changes in optical properties of reactants, e.g. red shift of the
DNA bands in UV–vis spectra [5], changes in circular dichroism
of the complexes [6], or excitation of ﬂuorescence of some indi-
cators (ethidium bromide [7]). Being universal, optical methods
are less appropriate for sensor mode and excessively sensitive
to matrix interferences affecting the response of target interac-
tions.
Electrochemical DNA-sensors are considered as an alterna-
tive to conventional spectroscopic techniques due to lesser cost,
high sensitivity of the response, compatibility with conventional
measurement equipment, intuitively understandable design and
simple measurement mode [8]. Three strategies are utilized for
electrochemical detection of antitumor drugs, i.e., (i) recording oxi-
dation of guanine (and to a less extent adenine) residues in the
DNA strand [9–12]; (ii) detecting signal referred to electrochem-
ically active drug affected by interaction with DNA [13–16]; and
(iii) monitoring changes in the surface layer morphology followed
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